Aperiomics

Aperiomics is a privately held biotechnology company based in Sterling, Virginia. With a team of nine employees, the company has generated $16 million in revenue. Aperiomics provides medical professionals with a unique service: identifying bacterial, viral, fungal, and parasitic infections through Deep Shotgun Metagenomic Sequencing. They utilize a vast database of over 37,000 microbes to pinpoint the specific cause of an infection, often when other tests are unable to do so. This service benefits patients who have struggled with undiagnosed illnesses for years, enabling doctors to provide targeted treatment and improve clinical outcomes. Aperiomics distinguishes itself as the only company globally offering this comprehensive and cutting-edge approach to infection identification. Their work has garnered recognition, including the Life Science Innovator of the Year award in 2016 and the International Start Up of the Year award in 2018. For more information about Aperiomics and their groundbreaking services, please visit their website at aperiomics.com.